{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T03:13:36Z","timestamp":1788837216751,"version":"build-2803163510"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurodegeneration"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The genomic locus that encodes the Leucine-rich repeat kinase 2 (LRRK2) gene is highly pleiotropic and associated with Parkinson\u2019s disease (PD). Coding variants associated with risk of PD act as gain of function kinase mutations increasing phosphorylation of RAB substrates, and non-coding variants in the promoter region of LRRK2 increase expression of the gene, notably in immune cells. If regulation of LRRK2 expression is a causal contributor to PD, it is important to understand the mechanism(s) by which LRRK2 is regulated, particularly in the context of inflammation. Here, we show that interferon-\u0263 exposure induces robust LRRK2 activation in human iPSC-derived microglia through signaling of the Janus-activated Kinase complex to phosphorylate STAT1, which then binds to the LRRK2 promoter and is associated with remodeling of chromatin structure in this genomic locus. Additional regulatory mechanisms include the stress-induced transcription factor and long non-coding RNA encoded at the same locus, resulting in increased LRRK2 mRNA levels. We also show evidence of the same effect in acutely cultured human brain slices. While we were unable to demonstrate any induction of Lrrk2 mRNA in the mouse brain, the introduction of a human bacterial artificial chromosome transgene into the mouse genome recapitulated sensitivity to interferon-\u0263 in microglia. A comparative genomic analysis across mammals suggests that these species differences are driven by regulatory regions upstream of LRRK2 that are specific to anthropoid primates. These results demonstrate that there are differences between species in how genes associated with human diseases are regulated and provide important information that should be incorporated in disease modeling.<\/jats:p>","DOI":"10.1186\/s13024-026-00938-0","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T08:25:59Z","timestamp":1773822359000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Inflammatory signaling differentially changes chromatin accessibility and gene expression of the PD- associated kinase LRRK2 between human and mice"],"prefix":"10.1186","volume":"21","author":[{"given":"Alexandra","family":"Beilina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Hyeon","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Landeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Chia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhui","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xylena","family":"Reed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changyoun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Kaganovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic J.","family":"Acri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"Brooks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Mann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kareem A.","family":"Zaghloul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise","family":"Marsan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Raphael Gibbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"DeCasien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark R.","family":"Cookson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,18]]},"reference":[{"issue":"7","key":"938_CR1","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1016\/j.cell.2018.05.051","volume":"173","author":"NR Wray","year":"2018","unstructured":"Wray NR, Wijmenga C, Sullivan PF, Yang J, Visscher PM. Common disease is more complex than implied by the core gene omnigenic model. Cell. 2018 Jun 14;173(7):1573\u201380.","journal-title":"Cell"},{"key":"938_CR2","doi-asserted-by":"crossref","unstructured":"Sudlow C, Gallacher J, Allen N, Beral V, Burton P, Danesh J, et al. UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 2015 Mar;12(3):e1001779.","DOI":"10.1371\/journal.pmed.1001779"},{"issue":"6","key":"938_CR3","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1016\/j.cell.2013.05.039","volume":"153","author":"C L\u00f3pez-Ot\u00edn","year":"2013","unstructured":"L\u00f3pez-Ot\u00edn C, Blasco MA, Partridge L, Serrano M, Kroemer G. The hallmarks of aging. Cell. 2013 Jun 6;153(6):1194\u2013217.","journal-title":"Cell"},{"issue":"4","key":"938_CR4","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.cell.2022.12.032","volume":"186","author":"DM Wilson","year":"2023","unstructured":"Wilson DM, Cookson MR, Van Den Bosch L, Zetterberg H, Holtzman DM, Dewachter I. Hallmarks of neurodegenerative diseases. Cell. 2023 Feb 16;186(4):693\u2013714.","journal-title":"Cell"},{"issue":"4","key":"938_CR5","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.neuron.2004.10.023","volume":"44","author":"C Pais\u00e1n-Ru\u00edz","year":"2004","unstructured":"Pais\u00e1n-Ru\u00edz C, Jain S, Evans EW, Gilks WP, Sim\u00f3n J, Van Der Brug M, et al. Cloning of the gene containing mutations that cause PARK8-linked Parkinson\u2019s disease. Neuron. 2004;44(4):595\u2013600.","journal-title":"Neuron"},{"key":"938_CR6","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.neuron.2004.11.005","volume":"44","author":"A Zimprich","year":"2004","unstructured":"Zimprich A, Biskup S, Leitner P, Lichtner P, Farrer M, Lincoln S, et al. Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron. 2004 Nov;44:601\u201307.","journal-title":"Neuron"},{"issue":"6","key":"938_CR7","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1002\/ana.20484","volume":"57","author":"M Funayama","year":"2005","unstructured":"Funayama M, Hasegawa K, Ohta E, Kawashima N, Komiyama M, Kowa H, et al. An LRRK2 mutation as a cause for the parkinsonism in the original PARK8 family. Ann Neurol. 2005 Jun;57(6):918\u201321.","journal-title":"Ann Neurol"},{"key":"938_CR8","unstructured":"Lim SY, Klein C. Parkinson\u2019s disease is predominantly a genetic disease. J Park Dis. 2024 Mar 25."},{"key":"938_CR9","doi-asserted-by":"publisher","unstructured":"The Global Parkinson\u2019s genetics program (GP2), Leonard HL. Novel Parkinson\u2019s disease genetic risk factors within and across European populations [internet]. Genetic Evidence Med. 2025. [cited 2025 Aug 28]. Available from: https:\/\/doi.org\/10.1101\/2025.03.14.24319455.","DOI":"10.1101\/2025.03.14.24319455"},{"key":"938_CR10","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41531-017-0010-8","volume":"3","author":"DA Cook","year":"2017","unstructured":"Cook DA, Kannarkat GT, Cintron AF, Butkovich LM, Fraser KB, Chang J, et al. LRRK2 levels in immune cells are increased in Parkinson\u2019s disease. NPJ Park Dis. 2017;3:11.","journal-title":"NPJ Park Dis"},{"issue":"6","key":"938_CR11","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1093\/brain\/awy077","volume":"141","author":"E Kozina","year":"2018","unstructured":"Kozina E, Sadasivan S, Jiao Y, Dou Y, Ma Z, Tan H, et al. Mutant LRRK2 mediates peripheral and central immune responses leading to neurodegeneration in vivo. Brain J Neurol. 2018 Jun 1;141(6):1753\u201369.","journal-title":"Brain J Neurol"},{"issue":"1","key":"938_CR12","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41531-022-00289-9","volume":"8","author":"E Kozina","year":"2022","unstructured":"Kozina E, Byrne M, Smeyne RJ. Mutant LRRK2 in lymphocytes regulates neurodegeneration via IL-6 in an inflammatory model of Parkinson\u2019s disease. NPJ Park Dis. 2022 Mar 15;8(1):24.","journal-title":"NPJ Park Dis"},{"key":"938_CR13","doi-asserted-by":"crossref","unstructured":"Langston RG, Beilina A, Reed X, Kaganovich A, Singleton AB, Blauwendraat C, et al. Association of a common genetic variant with Parkinson\u2019s disease is mediated by microglia. Sci Transl Med. 2022 Jul 27;14(655):eabp 8869.","DOI":"10.1126\/scitranslmed.abp8869"},{"issue":"2","key":"938_CR14","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1093\/hmg\/ddx410","volume":"27","author":"Z Liu","year":"2018","unstructured":"Liu Z, Bryant N, Kumaran R, Beilina A, Abeliovich A, Cookson MR, et al. LRRK2 phosphorylates membrane-bound Rabs and is activated by GTP-bound Rab7L1 to promote recruitment to the trans-Golgi network. Hum Mol Genet. 2018 Jan 15;27(2):385\u201395.","journal-title":"Hum Mol Genet"},{"key":"938_CR15","doi-asserted-by":"crossref","unstructured":"Bonet-Ponce L, Beilina A, Williamson CD, Lindberg E, Kluss JH, Saez-Atienzar S, et al. LRRK2 mediates tubulation and vesicle sorting from lysosomes. Sci Adv. 2020 Nov;6(46).","DOI":"10.1126\/sciadv.abb2454"},{"key":"938_CR16","doi-asserted-by":"crossref","unstructured":"Weindel CG, Bell SL, Vail KJ, West KO, Patrick KL, Watson RO. LRRK2 maintains mitochondrial homeostasis and regulates innate immune responses to Mycobacterium tuberculosis. eLife. 2020 Feb 14;9.","DOI":"10.7554\/eLife.51071"},{"key":"938_CR17","doi-asserted-by":"crossref","unstructured":"Herbst S, Campbell P, Harvey J, Bernard EM, Papayannopoulos V, Wood NW, et al. LRRK2 activation controls the repair of damaged endomembranes in macrophages. Embo J. 2020 Jul 9;e104494.","DOI":"10.15252\/embj.2020104494"},{"key":"938_CR18","doi-asserted-by":"crossref","unstructured":"H\u00e4rtlova A, Herbst S, Peltier J, Rodgers A, Bilkei-Gorzo O, Fearns A, et al. LRRK2 is a negative regulator of Mycobacterium tuberculosis phagosome maturation in macrophages. Embo J. 2018 15;37(12).","DOI":"10.15252\/embj.201798694"},{"issue":"11","key":"938_CR19","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","volume":"22","author":"MG Tansey","year":"2022","unstructured":"Tansey MG, Wallings RL, Houser MC, Herrick MK, Keating CE, Joers V. Inflammation and immune dysfunction in Parkinson disease. Nat Rev Immunol. 2022 Nov;22(11):657\u201373.","journal-title":"Nat Rev Immunol"},{"issue":"9","key":"938_CR20","first-page":"5577","volume":"185","author":"A Gardet","year":"2010","unstructured":"Gardet A, Benita Y, Li C, Sands BE, Ballester I, Stevens C, et al. LRRK2 is involved in the IFN-gamma response and host response to pathogens. J Immunol Baltim Md 1950. 2010 Nov 1;185(9):5577\u201385.","journal-title":"J Immunol Baltim Md 1950"},{"issue":"1","key":"938_CR21","doi-asserted-by":"publisher","first-page":"5163","DOI":"10.1038\/s41467-020-18755-4","volume":"11","author":"V Panagiotakopoulou","year":"2020","unstructured":"Panagiotakopoulou V, Ivanyuk D, De Cicco S, Haq W, Arsi\u0107 A, Yu C, et al. Interferon-\u03b3 signaling synergizes with LRRK2 in neurons and microglia derived from human induced pluripotent stem cells. Nat Commun. 2020 Oct 14;11(1):5163.","journal-title":"Nat Commun"},{"issue":"13","key":"938_CR22","doi-asserted-by":"publisher","first-page":"3327","DOI":"10.1038\/s44319-025-00473-x","volume":"26","author":"D Dikovskaya","year":"2025","unstructured":"Dikovskaya D, Pemberton R, Taylor M, Tasegian A, Bhattacharya P, Zeneviciute K, et al. Inflammation and IL-4 regulate Parkinson\u2019s and Crohn\u2019s disease associated kinase LRRK2. EMBO Rep. 2025 Jul;26(13):3327\u201356.","journal-title":"EMBO Rep"},{"issue":"5","key":"938_CR23","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1046\/j.1365-3083.1998.00435.x","volume":"48","author":"SR Paludan","year":"1998","unstructured":"Paludan SR. Interleukin-4 and interferon-gamma: the quintessence of a mutual antagonistic relationship. Scand J Immunol. 1998 Nov;48(5):459\u201368.","journal-title":"Scand J Immunol"},{"issue":"1","key":"938_CR24","doi-asserted-by":"publisher","first-page":"19454","DOI":"10.1038\/s41598-022-23477-2","volume":"12","author":"SJ Washer","year":"2022","unstructured":"Washer SJ, Perez-Alcantara M, Chen Y, Steer J, James WS, Trynka G, et al. Single-cell transcriptomics defines an improved, validated monoculture protocol for differentiation of human iPSC to microglia. Sci Rep. 2022 Nov 14;12(1):19454.","journal-title":"Sci Rep"},{"key":"938_CR25","doi-asserted-by":"publisher","first-page":"102354","DOI":"10.1016\/j.scr.2021.102354","volume":"53","author":"A Beylina","year":"2021","unstructured":"Beylina A, Langston RG, Rosen D, Reed X, Cookson MR. Generation of fourteen isogenic cell lines for Parkinson\u2019s disease-associated leucine-rich repeat kinase (LRRK2). STEM Cell Res. 2021 May;53:102354.","journal-title":"STEM Cell Res"},{"issue":"12","key":"938_CR26","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1016\/j.stem.2022.11.004","volume":"29","author":"CB Pantazis","year":"2022","unstructured":"Pantazis CB, Yang A, Lara E, McDonough JA, Blauwendraat C, Peng L, et al. A reference human induced pluripotent stem cell line for large-scale collaborative studies. Cell STEM Cell. 2022 Dec 1;29(12):1685\u2013702.e22.","journal-title":"Cell STEM Cell"},{"issue":"2","key":"938_CR27","first-page":"119","volume":"2","author":"FR Kreitzer","year":"2013","unstructured":"Kreitzer FR, Salomonis N, Sheehan A, Huang M, Park JS, Spindler MJ, et al. A robust method to derive functional neural crest cells from human pluripotent stem cells. Am J STEM Cells. 2013;2(2):119\u201331.","journal-title":"Am J STEM Cells"},{"issue":"4","key":"938_CR28","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.cell.2018.01.029","volume":"172","author":"SA Lambert","year":"2018","unstructured":"Lambert SA, Jolma A, Campitelli LF, Das PK, Yin Y, Albu M, et al. The human transcription factors. Cell. 2018 Feb 8;172(4):650\u201365.","journal-title":"Cell"},{"issue":"48","key":"938_CR29","doi-asserted-by":"publisher","first-page":"84595","DOI":"10.18632\/oncotarget.21102","volume":"8","author":"TK Sears","year":"2017","unstructured":"Sears TK, Angelastro JM. The transcription factor ATF5: role in cellular differentiation, stress responses, and cancer. Oncotarget. 2017 Oct 13;8(48):84595\u2013609.","journal-title":"Oncotarget"},{"key":"938_CR30","doi-asserted-by":"publisher","first-page":"1478352","DOI":"10.3389\/fgene.2024.1478352","volume":"15","author":"JDF Poloni","year":"2024","unstructured":"Poloni JDF, Oliveira FD, Feltes BC. Localization is the key to action: regulatory peculiarities of lncRnas. Front Genet. 2024;15:1478352.","journal-title":"Front Genet"},{"issue":"44","key":"938_CR31","doi-asserted-by":"publisher","first-page":"13971","DOI":"10.1523\/JNEUROSCI.3799-09.2009","volume":"29","author":"L Parisiadou","year":"2009","unstructured":"Parisiadou L, Xie C, Cho HJ, Lin X, Gu XL, Long CX, et al. Phosphorylation of ezrin\/radixin\/moesin proteins by LRRK2 promotes the rearrangement of actin cytoskeleton in neuronal morphogenesis. J Neurosci Off J Soc Neurosci. 2009 Nov 4;29(44):13971\u201380.","journal-title":"J Neurosci Off J Soc Neurosci"},{"issue":"6","key":"938_CR32","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1007\/s11064-018-2650-4","volume":"44","author":"RG Langston","year":"2019","unstructured":"Langston RG, Rudenko IN, Kumaran R, Hauser DN, Kaganovich A, Ponce LB, et al. Differences in stability, activity and mutation effects between human and mouse Leucine-rich repeat kinase 2. Neurochem Res. 2019 Jun;44(6):1446\u201359.","journal-title":"Neurochem Res"},{"issue":"7","key":"938_CR33","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/j.neuron.2022.12.029","volume":"111","author":"KS Levine","year":"2023","unstructured":"Levine KS, Leonard HL, Blauwendraat C, Iwaki H, Johnson N, Bandres-Ciga S, et al. Virus exposure and neurodegenerative disease risk across national biobanks. Neuron. 2023 Apr 5;111(7):1086\u201393.e2.","journal-title":"Neuron"},{"issue":"7","key":"938_CR34","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1016\/j.cell.2019.11.010","volume":"179","author":"L Geirsdottir","year":"2019","unstructured":"Geirsdottir L, David E, Keren-Shaul H, Weiner A, Bohlen SC, Neuber J, et al. Cross-species single-cell analysis reveals divergence of the primate microglia program. Cell. 2019 Dec 12;179(7):1609\u201322.e16.","journal-title":"Cell"},{"key":"938_CR35","doi-asserted-by":"publisher","first-page":"102482","DOI":"10.1016\/j.ceb.2025.102482","volume":"93","author":"A Bentley-DeSousa","year":"2025","unstructured":"Bentley-DeSousa A, Clegg D, Ferguson SM. LRRK2, lysosome damage, and Parkinson\u2019s disease. Curr Opin Cell Biol. 2025 Apr;93:102482.","journal-title":"Curr Opin Cell Biol"},{"issue":"6","key":"938_CR36","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1093\/jb\/mvad064","volume":"174","author":"T Taguchi","year":"2023","unstructured":"Taguchi T. Membrane traffic governs the STING inflammatory signalling. J Biochem (Tokyo). 2023 Nov 30;174(6):483\u201390.","journal-title":"J Biochem (Tokyo)"},{"issue":"9","key":"938_CR37","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/s41580-020-0244-x","volume":"21","author":"KP Hopfner","year":"2020","unstructured":"Hopfner KP, Hornung V. Molecular mechanisms and cellular functions of cGAS-STING signalling. Nat Rev Mol Cell Biol. 2020 Sep;21(9):501\u201321.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6","key":"938_CR38","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1038\/s44319-025-00405-9","volume":"26","author":"O Scott","year":"2025","unstructured":"Scott O, Saran E, Freeman SA. The spectrum of lysosomal stress and damage responses: from mechanosensing to inflammation. EMBO Rep. 2025 Mar;26(6):1425\u201339.","journal-title":"EMBO Rep"},{"key":"938_CR39","doi-asserted-by":"crossref","unstructured":"Liu W, Zhu P, Li M, Li Z, Yu Y, Liu G, et al. Large-scale across species transcriptomic analysis identifies genetic selection signatures associated with longevity in mammals. Embo J. 2023 Sep 4;42(17):e112740.","DOI":"10.15252\/embj.2022112740"},{"key":"938_CR40","doi-asserted-by":"crossref","unstructured":"Iannotta L, Biosa A, Kluss JH, Tombesi G, Kaganovich A, Cogo S, et al. Divergent effects of G2019S and R1441C LRRK2 mutations on LRRK2 and Rab10 phosphorylations in mouse tissues. Cells. 2020 Oct 22;9(11):E2344.","DOI":"10.3390\/cells9112344"},{"issue":"10","key":"938_CR41","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1002\/mds.27059","volume":"32","author":"AJ Lee","year":"2017","unstructured":"Lee AJ, Wang Y, Alcalay RN, Mejia-Santana H, Saunders-Pullman R, Bressman S, et al. Penetrance estimate of LRRK2 p.G2019S mutation in individuals of non-Ashkenazi Jewish ancestry: LRRK2 mutation in non-Ashkenazi Jewish ancestry. Mov Disord. 2017 Oct;32(10):1432\u201338.","journal-title":"Mov Disord"},{"issue":"10","key":"938_CR42","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1002\/mds.27776","volume":"34","author":"M Vila","year":"2019","unstructured":"Vila M. Neuromelanin, aging, and neuronal vulnerability in Parkinson\u2019s disease. Mov Disord Off J Mov Disord Soc. 2019 Oct;34(10):1440\u201351.","journal-title":"Mov Disord Off J Mov Disord Soc"},{"issue":"1","key":"938_CR43","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1038\/s42003-025-08544-4","volume":"8","author":"L Blasco-Agell","year":"2025","unstructured":"Blasco-Agell L, Pons-Espinal M, Testa V, Roch G, Montero-Mu\u00f1oz J, Fernandez-Carasa I, et al. LRRK2-mutant microglia and neuromelanin synergize to drive dopaminergic neurodegeneration in an iPSC-based Parkinson\u2019s disease model. Commun Biol. 2025, Aug 12;8(1):1203.","journal-title":"Commun Biol"},{"issue":"2","key":"938_CR44","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s00401-023-02595-9","volume":"146","author":"D Cabezudo","year":"2023","unstructured":"Cabezudo D, Tsafaras G, Van Acker E, Van den Haute C, Baekelandt V. Mutant LRRK2 exacerbates immune response and neurodegeneration in a chronic model of experimental colitis. Acta Neuropathol (Berl). 2023 Aug;146(2):245\u201361.","journal-title":"Acta Neuropathol (Berl)"},{"issue":"4","key":"938_CR45","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1002\/mds.28890","volume":"37","author":"CH Lin","year":"2022","unstructured":"Lin CH, Lin HY, Ho EP, Ke YC, Cheng MF, Shiue CY, et al. Mild chronic colitis triggers parkinsonism in LRRK2 mutant mice through activating TNF-\u03b1 pathway. Mov Disord Off J Mov Disord Soc. 2022 Apr;37(4):745\u201357.","journal-title":"Mov Disord Off J Mov Disord Soc"},{"key":"938_CR46","doi-asserted-by":"publisher","first-page":"102558","DOI":"10.1016\/j.scr.2021.102558","volume":"56","author":"X Reed","year":"2021","unstructured":"Reed X, Cobb MM, Skinbinski G, Roosen D, Kaganovich A, Ding J, et al. Transcriptional signatures in iPSC-derived neurons are reproducible across labs when differentiation protocols are closely matched. STEM Cell Res. 2021 Oct;56:102558.","journal-title":"STEM Cell Res"},{"issue":"3","key":"938_CR47","doi-asserted-by":"publisher","first-page":"100261","DOI":"10.1016\/j.xgen.2023.100261","volume":"3","author":"E Bressan","year":"2023","unstructured":"Bressan E, Reed X, Bansal V, Hutchins E, Cobb MM, Webb MG, et al. The foundational data initiative for Parkinson disease: enabling efficient translation from genetic maps to mechanism. Cell Genomics. 2023 Mar 8;3(3):100261.","journal-title":"Cell Genomics"},{"issue":"4","key":"938_CR48","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.jgg.2021.01.003","volume":"48","author":"J Zhong","year":"2021","unstructured":"Zhong J, Tang G, Zhu J, Wu W, Li G, Lin X, et al. Single-cell brain atlas of Parkinson\u2019s disease mouse model. J Genet Genomics Yi Chuan Xue Bao. 2021 Apr 20;48(4):277\u201388.","journal-title":"J Genet Genomics Yi Chuan Xue Bao"},{"key":"938_CR49","doi-asserted-by":"crossref","unstructured":"Perez G, Barber GP, Benet-Pages A, Casper J, Clawson H, Diekhans M, et al. The UCSC genome browser database: 2025 update. Nucleic Acids Res. 2025 Jan 6;53(D1):D1243\u20139.","DOI":"10.1093\/nar\/gkae974"},{"issue":"7833","key":"938_CR50","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/s41586-020-2871-y","volume":"587","author":"J Armstrong","year":"2020","unstructured":"Armstrong J, Hickey G, Diekhans M, Fiddes IT, Novak AM, Deran A, et al. Progressive Cactus is a multiple-genome aligner for the thousand-genome era. Nature. 2020 Nov;587(7833):246\u201351.","journal-title":"Nature"},{"key":"938_CR51","unstructured":"Christmas MJ, Kaplow IM, Genereux DP, Dong MX, Hughes GM, Li X, et al. Evolutionary constraint and innovation across hundreds of placental mammals. Science. 2023 Apr 28;380(6643):eabn 3943."},{"key":"938_CR52","unstructured":"Zoonomia Consortium. A comparative genomics multitool for scientific discovery and conservation. Nature. 2020 Nov;587(7833):240\u201345."},{"issue":"6648","key":"938_CR53","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1126\/science.abn7829","volume":"380","author":"LFK Kuderna","year":"2023","unstructured":"Kuderna LFK, Gao H, Janiak MC, Kuhlwilm M, Orkin JD, Bataillon T, et al. A global catalog of whole-genome diversity from 233 primate species. Science. 2023 Jun 2;380(6648):906\u201313.","journal-title":"Science"},{"issue":"7996","key":"938_CR54","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1038\/s41586-023-06798-8","volume":"625","author":"LFK Kuderna","year":"2024","unstructured":"Kuderna LFK, Ulirsch JC, Rashid S, Ameen M, Sundaram L, Hickey G, et al. Identification of constrained sequence elements across 239 primate genomes. Nature. 2024 Jan;625(7996):735\u201342.","journal-title":"Nature"},{"key":"938_CR55","doi-asserted-by":"crossref","unstructured":"Kumar S, Suleski M, Craig JM, Kasprowicz AE, Sanderford M, Li M, et al. TimeTree, 5: an expanded resource for species Divergence times. Mol Biol Evol. 2022 Aug 6;39(8):msac174.","DOI":"10.1093\/molbev\/msac174"},{"key":"938_CR56","doi-asserted-by":"crossref","unstructured":"Vorontsov IE, Eliseeva IA, Zinkevich A, Nikonov M, Abramov S, Boytsov A, et al. HOCOMOCO in 2024: a rebuild of the curated collection of binding models for human and mouse transcription factors. Nucleic Acids Res. 2024 Jan 5;52(D1):D154\u201363.","DOI":"10.1093\/nar\/gkad1077"},{"issue":"10","key":"938_CR57","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1093\/bioinformatics\/btw024","volume":"32","author":"G Tan","year":"2016","unstructured":"Tan G, Lenhard B. Tfbstools: an R\/bioconductor package for transcription factor binding site analysis. Bioinforma Oxf Engl. 2016 May 15;32(10):1555\u201356.","journal-title":"Bioinforma Oxf Engl"}],"container-title":["Molecular Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13024-026-00938-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-026-00938-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-026-00938-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:23:35Z","timestamp":1781641415000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13024-026-00938-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,18]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["938"],"URL":"https:\/\/doi.org\/10.1186\/s13024-026-00938-0","relation":{},"ISSN":["1750-1326"],"issn-type":[{"value":"1750-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,18]]},"assertion":[{"value":"30 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Animal work was approved by the NIA Animal Care and Use Committee, consistent with guidelines presented in the Public Health Service (PHS) Policy on Humane Care and Use of Laboratory Animals. For human samples, participants with drug-resistant epilepsy underwent a surgical procedure in which the brain regions involved in their seizure activity were surgically removed. The participants took part in the current study voluntarily and without monetary rewards. All participants consented to the research protocol approved by the Institutional Review Board at the National Institutes of Health (NIH, Bethesda MD; protocol reference number 11-\n                      N\n                      -0051) in accordance with the Declaration of Helsinki. All cortical samples used for this study were resected from brain regions that were included in the standard of care surgical resection for treatment of their epilepsy.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"24"}}